Evidence map›Paper›PMID 19332537›Full record

ArticleThe Journal of biological chemistry2009

p90 ribosomal S6 kinase and p70 ribosomal S6 kinase link phosphorylation of the eukaryotic chaperonin containing TCP-1 to growth factor, insulin, and nutrient signaling.

Yuki Abe, Sang-Oh Yoon, Kazuishi Kubota, Michelle C Mendoza, Steven P Gygi, John Blenis

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. S6 kinase 1 at the central node of cell size and ageing.Frontiers in cell and developmental biology · 2022
    Review
  15. Article
  16. The TRiCky Business of Protein Folding in Health and Disease.Frontiers in cell and developmental biology · 2022
    Review
  17. mTORC1-chaperonin CCT signaling regulates mProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Folding for the Immune Synapse: CCT Chaperonin and the Cytoskeleton.Frontiers in cell and developmental biology · 2021
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yuki AbeDepartment of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Sang-Oh Yoon
Kazuishi Kubota
Michelle C Mendoza
Steven P Gygi
John Blenis
Harvard University · US

Funding

SIGNAL TRANSDUCTION TO PP70 S6KR01GM051405 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI BLENIS, JOHN · 1995 to 2023
$14.0M
Mitogenic and Oncogenic Regulation of ERK/RSK SignalingR37CA046595 · NCI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI BLENIS, JOHN · 2003 to 2012
$6.4M
New Technologies for Quantitative Phosphorylation AnalysisR01HG003456 · NHGRI · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI GYGI, STEVEN P · 2005 to 2011
$2.7M
NCI NIH HHS R37CA046595NHGRI NIH HHS HG3456NIGMS NIH HHS R01GM051405
6 · The paper itself

Abstract

Chaperonin containing TCP-1 (CCT) is a large multisubunit complex that mediates protein folding in eukaryotic cells. CCT participates in the folding of newly synthesized polypeptides, including actin, tubulin, and several cell cycle regulators; therefore, CCT plays an important role in cytoskeletal organization and cell division. Here we identify the chaperonin CCT as a novel physiological substrate for p90 ribosomal S6 kinase (RSK) and p70 ribosomal S6 kinase (S6K). RSK phosphorylates the beta subunit of CCT in response to tumor promoters or growth factors that activate the Ras-mitogen-activated protein kinase (MAPK) pathway. CCTbeta Ser-260 was identified as the RSK site by mass spectrometry and confirmed by site-directed mutagenesis. RSK-dependent Ser-260 phosphorylation was sensitive to the MEK inhibitor UO126 and the RSK inhibitor BID-1870. Insulin weakly activates RSK but strongly activates the phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway and utilizes S6K to regulate CCTbeta phosphorylation. Thus, the Ras-MAPK and PI3K-mTOR pathways converge on CCTbeta Ser-260 phosphorylation in response to multiple agonists in various mammalian cells. We also show that RNA interference-mediated knockdown of endogenous CCTbeta causes impaired cell proliferation that can be rescued with ectopically expressed murine CCTbeta wild-type or phosphomimetic mutant S260D, but not the phosphorylation-deficient mutant S260A. Although the molecular mechanism of CCTbeta regulation remains unclear, our findings demonstrate a link between oncogene and growth factor signaling and chaperonin CCT-mediated cellular activities.

Indexed as

Signal TransductionAmino Acid SequenceAnimalsAntibodiesCell LineCell ProliferationChaperonin Containing TCP-1ChaperoninsEukaryotic CellsHumansInsulinIntercellular Signaling Peptides and ProteinsMiceMitogen-Activated Protein KinasesMolecular Sequence DataPhosphatidylinositol 3-KinasesAntibodiesCCT2 protein, humanChaperonin Containing TCP-1ChaperoninsInsulinIntercellular Signaling Peptides and ProteinsMitogen-Activated Protein KinasesMTOR protein, humanmTOR protein, mousePhosphatidylinositol 3-KinasesPhosphoserineProtein KinasesProtein Subunitsras ProteinsRibosomal Protein S6 Kinases, 70-kDaRibosomal Protein S6 Kinases, 90-kDaTcp1 protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID19332537
PMCPMC2685676
OpenAlexW2046747899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.